Go to
JCI Insight
Citations to this article
Robert S. Sherwin
Published June 1, 1978
Citation Information: J Clin Invest. 1978;61(6):1471-1481. https://doi.org/10.1172/JCI109067.
Citation Information: J Clin Invest. 1978;61(6):1471-1481. https://doi.org/10.1172/JCI109067.
Abstract
l-Leucine was administered as a primed continuous 3-4-h infusion in nonobese and obese subjects in the postabsorptive state and for 12 h in obese subjects after a 3-day and 4-wk fast. In nonobese and obese subjects studied in the post-absorptive state, the leucine infusion resulted in a 150-200% rise in plasma leucine above preinfusion levels, a small decrease in plasma glucose, and unchanged levels of plasma insulin and glucagon and blood ketones. Plasma isoleucine (60-70%) and valine (35-40%) declined to a greater extent than other amino acids (P < 0.001).
Authors
Robert S. Sherwin
Total citations by year
Citation information
Citations to this article in year 2017 (1)
| Title and authors | Publication | Year |
|---|---|---|
|
Abnormal circulating amino acid profiles in multiple metabolic disorders
AP Okekunle, Y Li, L Liu, S Du, X Wu, Y Chen, Y Li, J Qi, C Sun, R Feng |
Diabetes Research and Clinical Practice | 2017 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)